Sort   by:  
 Page size 
UnknownSafety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Not available
S-EPMC7723445 | biostudies-literature
UnknownAntibody evasion by the P.1 strain of SARS-CoV-2.
Not available
S-EPMC8008340 | biostudies-literature
UnknownReduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.
Not available
S-EPMC8218332 | biostudies-literature
UnknownInherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration.
Not available
S-EPMC5340123 | biostudies-literature
UnknownAdult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study.
Not available
S-EPMC5644573 | biostudies-literature
UnknownAdult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.
Not available
S-EPMC5931085 | biostudies-literature
UnknownGenome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.
Not available
S-EPMC4063682 | biostudies-literature
UnknownSingle-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Not available
S-EPMC7894131 | biostudies-literature
UnknownShared genetics underlying epidemiological association between endometriosis and ovarian cancer.
Not available
S-EPMC4581608 | biostudies-literature
Unknownrs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.
Not available
S-EPMC6163881 | biostudies-literature
Sort   by:  
 Page size